PF-04620110
PF-04620110 is a potent, selective and orally bioavailable diglyceride acyltransferase-1 (DGAT-1) inhibitor with an IC50 of 19 nM[1].
Product Specifications
CAS Number
[1109276-89-2]
UNSPSC
12352005
Hazard Statement
H302
Target
Acyltransferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/PF-04620110.html
Purity
99.60
Solubility
DMSO : 12.5 mg/mL (ultrasonic)
Smiles
O=C(C[C@@H]1CC[C@H](CC1)C2=CC=C(C=C2)N3CCOC4=NC=NC(N)=C4C3=O)O
Molecular Formula
C21H24N4O4
Molecular Weight
396.44
Precautions
H302
References & Citations
[1]Dow RL, et al. Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core. Bioorg Med Chem Lett. 2011 Oct 15;21 (20) :6122-5.|[2]Dow RL, et al. Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1. ACS Med Chem Lett. 2011 Mar 18;2 (5) :407-12.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
48461121 3x 1.0µg DNA
TRNAV6 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details 
GTR15097655 1 Vial
Lentiviral human PFKP shRNA (UAS) - Lentiviral human PFKP shRNA (UAS, RFP) (25)
Ask
View Details 
GTR15152796 1 Vial
Lentiviral human RMND1 shRNA (UAS) - Lentiviral human RMND1 shRNA (UAS, RFP) (100)
Ask
View Details